EKF Diagnostics Holdings PLC EKF

Morningstar Rating
GBX24.60 −0.10 (0.40%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EKF is trading at a LOCK|cz#nrd premium.
Price
£0.25
Fair Value
LOCK|ZRwc!>w
Uncertainty
LOCK|qpLK%
1-Star Price
LOCK|!%pv&pQ
5-Star Price
LOCK|tm@@#L
Economic Moat
LOCK|&z%
Capital Allocation
—

Trading Information

Previous Close Price
GBX24.70
Day Range
GBX24.20–24.60
52-Week Range
GBX21.80–31.80
Bid/Ask
GBX0.00 / GBX0.00
Shares Outstanding
427.97M
Market Cap
GBX10.53B
Volume/Avg
14,337 / 423,477

Key Statistics

Price/Earnings (Normalized)
50.50
Price/Sales
2.11
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
4.72%

Company Profile

EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
301

Valuation

Metric
EKF
Price/Earnings (Normalized)
50.50
Price/Book Value
1.51
Price/Sales
2.11
Price/Cash Flow
11.95
Price/Earnings
EKF

Financial Strength

Metric
EKF
Quick Ratio
3.03
Current Ratio
4.72
Interest Coverage
41.74
Quick Ratio
EKF

Profitability

Metric
EKF
Return on Assets (Normalized)
3.64%
Return on Equity (Normalized)
4.23%
Return on Invested Capital (Normalized)
3.92%
Return on Assets
EKF

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|t#mbzz&LOCK|<CbL$167B
Medtronic PLC
MDT
LOCK|tfClr^LOCK|m<@F$111B
Stryker Corp
SYK
LOCK|r^$$rv@LLOCK|pnb$105B
Boston Scientific Corp
BSX
LOCK|PTr%xWLOCK|^H%p$63B
Edwards Lifesciences Corp
EW
LOCK|fkYx>hgSLOCK|^<!>?$49B
DexCom Inc
DXCM
LOCK|@Pcx#%LnLOCK|$kGx$33B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|#D%Jb#LOCK|@S$29B
Koninklijke Philips NV ADR
PHG
LOCK|ZzLOCK|^wT$23B
Steris PLC
STE
LOCK|@L^!M$LOCK|MlHB^$20B
Zimmer Biomet Holdings Inc
ZBH
LOCK|<H^$&>?JLOCK|LB!$17B

Sponsor Center